About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?
Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...